445 related articles for article (PubMed ID: 29321662)
1. Breast cancer metastasis to liver and lung is facilitated by Pit-1-CXCL12-CXCR4 axis.
Martinez-Ordoñez A; Seoane S; Cabezas P; Eiro N; Sendon-Lago J; Macia M; Garcia-Caballero T; Gonzalez LO; Sanchez L; Vizoso F; Perez-Fernandez R
Oncogene; 2018 Mar; 37(11):1430-1444. PubMed ID: 29321662
[TBL] [Abstract][Full Text] [Related]
2. POU1F1 transcription factor promotes breast cancer metastasis via recruitment and polarization of macrophages.
Seoane S; Martinez-Ordoñez A; Eiro N; Cabezas-Sainz P; Garcia-Caballero L; Gonzalez LO; Macia M; Sanchez L; Vizoso F; Perez-Fernandez R
J Pathol; 2019 Nov; 249(3):381-394. PubMed ID: 31292963
[TBL] [Abstract][Full Text] [Related]
3. Cancer progression by breast tumors with Pit-1-overexpression is blocked by inhibition of metalloproteinase (MMP)-13.
Sendon-Lago J; Seoane S; Eiro N; Bermudez MA; Macia M; Garcia-Caballero T; Vizoso FJ; Perez-Fernandez R
Breast Cancer Res; 2014 Dec; 16(6):505. PubMed ID: 25527274
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic silencing of CXCL12 increases the metastatic potential of mammary carcinoma cells.
Wendt MK; Cooper AN; Dwinell MB
Oncogene; 2008 Feb; 27(10):1461-71. PubMed ID: 17724466
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer metastasis: demonstration that FOXP3 regulates CXCR4 expression and the response to CXCL12.
Douglass S; Meeson AP; Overbeck-Zubrzycka D; Brain JG; Bennett MR; Lamb CA; Lennard TW; Browell D; Ali S; Kirby JA
J Pathol; 2014 Sep; 234(1):74-85. PubMed ID: 24870556
[TBL] [Abstract][Full Text] [Related]
6. CXCL12-CXCR4 axis promotes the natural selection of breast cancer cell metastasis.
Sun Y; Mao X; Fan C; Liu C; Guo A; Guan S; Jin Q; Li B; Yao F; Jin F
Tumour Biol; 2014 Aug; 35(8):7765-73. PubMed ID: 24810923
[TBL] [Abstract][Full Text] [Related]
7. Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasis.
Darash-Yahana M; Pikarsky E; Abramovitch R; Zeira E; Pal B; Karplus R; Beider K; Avniel S; Kasem S; Galun E; Peled A
FASEB J; 2004 Aug; 18(11):1240-2. PubMed ID: 15180966
[TBL] [Abstract][Full Text] [Related]
8. CXCR4 receptor blockage reduces the contribution of tumor and stromal cells to the metastatic growth in the liver.
Benedicto A; Romayor I; Arteta B
Oncol Rep; 2018 Apr; 39(4):2022-2030. PubMed ID: 29436696
[TBL] [Abstract][Full Text] [Related]
9. CXCL12-mediated HOXB5 overexpression facilitates Colorectal Cancer metastasis through transactivating CXCR4 and ITGB3.
Feng W; Huang W; Chen J; Qiao C; Liu D; Ji X; Xie M; Zhang T; Wang Y; Sun M; Tian D; Fan D; Nie Y; Wu K; Xia L
Theranostics; 2021; 11(6):2612-2633. PubMed ID: 33456563
[No Abstract] [Full Text] [Related]
10. COUP-TFI modifies CXCL12 and CXCR4 expression by activating EGF signaling and stimulates breast cancer cell migration.
Boudot A; Kerdivel G; Lecomte S; Flouriot G; Desille M; Godey F; Leveque J; Tas P; Le Dréan Y; Pakdel F
BMC Cancer; 2014 Jun; 14():407. PubMed ID: 24906407
[TBL] [Abstract][Full Text] [Related]
11. Krüppel-like factor 8 activates the transcription of C-X-C cytokine receptor type 4 to promote breast cancer cell invasion, transendothelial migration and metastasis.
Mukherjee D; Lu H; Yu L; He C; Lahiri SK; Li T; Zhao J
Oncotarget; 2016 Apr; 7(17):23552-68. PubMed ID: 26993780
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Dipeptidyl Peptidase-4 Accelerates Epithelial-Mesenchymal Transition and Breast Cancer Metastasis via the CXCL12/CXCR4/mTOR Axis.
Yang F; Takagaki Y; Yoshitomi Y; Ikeda T; Li J; Kitada M; Kumagai A; Kawakita E; Shi S; Kanasaki K; Koya D
Cancer Res; 2019 Feb; 79(4):735-746. PubMed ID: 30584072
[TBL] [Abstract][Full Text] [Related]
13. The CXCL12-CXCR4 chemokine pathway: a novel axis regulates lymphangiogenesis.
Zhuo W; Jia L; Song N; Lu XA; Ding Y; Wang X; Song X; Fu Y; Luo Y
Clin Cancer Res; 2012 Oct; 18(19):5387-98. PubMed ID: 22932666
[TBL] [Abstract][Full Text] [Related]
14. Activation of STAT3 is involved in malignancy mediated by CXCL12-CXCR4 signaling in human breast cancer.
Liu X; Xiao Q; Bai X; Yu Z; Sun M; Zhao H; Mi X; Wang E; Yao W; Jin F; Zhao L; Ren J; Wei M
Oncol Rep; 2014 Dec; 32(6):2760-8. PubMed ID: 25310198
[TBL] [Abstract][Full Text] [Related]
15. New insight into the SDF-1/CXCR4 axis in a breast carcinoma model: hypoxia-induced endothelial SDF-1 and tumor cell CXCR4 are required for tumor cell intravasation.
Jin F; Brockmeier U; Otterbach F; Metzen E
Mol Cancer Res; 2012 Aug; 10(8):1021-31. PubMed ID: 22767589
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of CXC chemokine receptor 4-CXC chemokine ligand 12 axis ininvasive breast carcinoma: A potent biomarker predicting lymph node metastasis.
Dayer R; Babashah S; Jamshidi S; Sadeghizadeh M
J Cancer Res Ther; 2018; 14(2):345-350. PubMed ID: 29516917
[TBL] [Abstract][Full Text] [Related]
17. The CXCR4/CXCR7/CXCL12 Axis Is Involved in a Secondary but Complex Control of Neuroblastoma Metastatic Cell Homing.
Mühlethaler-Mottet A; Liberman J; Ascenção K; Flahaut M; Balmas Bourloud K; Yan P; Jauquier N; Gross N; Joseph JM
PLoS One; 2015; 10(5):e0125616. PubMed ID: 25955316
[TBL] [Abstract][Full Text] [Related]
18. CXCR4 and its ligand CXCL12 display opposite expression profiles in feline mammary metastatic disease, with the exception of HER2-overexpressing tumors.
Marques CS; Santos AR; Gameiro A; Correia J; Ferreira F
BMC Cancer; 2018 Jul; 18(1):741. PubMed ID: 30012106
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D Regulates CXCL12/CXCR4 and Epithelial-to-Mesenchymal Transition in a Model of Breast Cancer Metastasis to Lung.
Li J; Luco AL; Camirand A; St-Arnaud R; Kremer R
Endocrinology; 2021 Jul; 162(7):. PubMed ID: 33693593
[TBL] [Abstract][Full Text] [Related]
20. HMGA1B/2 transcriptionally activated-POU1F1 facilitates gastric carcinoma metastasis via CXCL12/CXCR4 axis-mediated macrophage polarization.
Tang C; Lei X; Xiong L; Hu Z; Tang B
Cell Death Dis; 2021 Apr; 12(5):422. PubMed ID: 33927188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
